We compared pre-treatment plasma fibrinogen levels between non-recurrent and recurrent groups of patients in each FIGO tumour stage.
Gender and age distribution was similar between the children with wheezing and controls, and between the children with non-recurrent and recurrent wheezing.
Although all nine miRNAs showed the same trend when comparing the non-recurrent and recurrent primary groups as observed in the primary with metastasis comparison, none of the differences were significant (Supplementary Figure 3).
Although all nine miRNAs that we validated by qRT PCR showed the same trend when comparing non-recurrent and recurrent primary melanomas as observed in the primary with metastasis comparison, none of the differences were significant.
Thus Fig. 4 shows that: In both non-recurrent and recurrent cases, the postoperative midline displacement on the 1st postoperative day was significantly reduced in both the unilateral and bilateral groups when compared with the preoperative values (p < 0.001).
In both non-recurrent and recurrent cases, the postoperative midline displacement on the 1st postoperative day was significantly reduced in both the unilateral and bilateral groups when compared with the preoperative values (p < 0.001).
In both non-recurrent and recurrent cases, the thickness of residual haematoma cavity on the 1st postoperative day was significantly reduced in the unilateral and bilateral groups when compared with the preoperative values (p < 0.001).
Thus Fig. 3 shows that: In both non-recurrent and recurrent cases, the thickness of residual haematoma cavity on the 1st postoperative day was significantly reduced in the unilateral and bilateral groups when compared with the preoperative values (p < 0.001).
Then, the clinical characteristics were compared between asymptomatic patients, no recurrent patients (BI-no recurrence) and recurrent patients (BI-recurrence).
Previous medical history included recurrent pneumonia, recurrent bronchitis, and recurrent upper respiratory tract infection (RURTI) in 349/1298 (26.9%) children; eczema in 130 (10.0%) children; asthma in 53 (4.1%) children; and allergic rhinitis in 56 (4.3%) children.
